A Single Arm, Single Center, Phase II Clinical Study of Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Cancer Interventions: Drug: Combination of pembrolizumab and platinum containing dual drugs Sponsors: Tongji University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Esophagus Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research | Skin Cancer | Squamous Cell Carcinoma | Study